Abstract:Background Bacterial meningitis remains a big threat to the integrity of the central nervous system (CNS), despite the advancements in antimicrobial reagents. Escherichia coli is a bacterial pathogen that can disrupt the CNS function, especially in neonates. E. coli meningitis occurs after bacteria invade the brain microvascular endothelial cells (BMECs) that form a direct and essential barrier restricting the entry of circulating microbes and toxins to the brain. Previous studies have reported on several cellular proteins that function during meningitic E. coli infections; however, more comprehensive investigations to elucidate the potential targets involved in E. coli meningitis are essential to better understand this disease and discover new treatments for it. Methods The isobaric tags for relative and absolute quantification (iTRAQ) approach coupled with LC-MS/MS were applied to compare and characterize the different proteomic profiles of BMECs in response to meningitic or non-meningitic E. coli strains. KEGG and gene ontology annotations, ingenuity pathways analysis, and functional experiments were combined to identify the key host molecules involved in the meningitic E. coli -induced tight junction breakdown and neuroinflammatory responses. Results A total of 13 cellular proteins were found to be differentially expressed by meningitic E. coli strains PCN033 and RS218, including one that was also affected by HB101, a non-meningitic E. coli strain. Through bioinformatics analysis, we identified the macrophage migration inhibitory factor (MIF), granzyme A, NF-κB signaling, and mitogen-activated protein kinase (MAPK) pathways as being biologically involved in the meningitic E. coli -induced tight junction breakdown and neuroinflammation. Functionally, we showed that MIF facilitated meningitic E. coli -induced production of cytokines and chemokines and also helped to disrupt the blood-brain barrier by decreasing the expression of tight junction proteins like ZO-1, occludin. Moreover, we demonstrated the significant activation of NF-κB and MAPK signaling in BMECs in response to meningitic E. coli strains, which dominantly determined the generation of the proinflammatory cytokines including IL-6, IL-8, TNF-α, and IL-1β. Conclusions Our work identified 12 host cellular targets that are affected by meningitic E. coli strains and revealed MIF to be an important contributor to meningitic E. coli -induced cytokine production and tight junction disruption, and also the NF-κB and MAPK signaling pathways that are mainly involved in the infection-induced cytokines production. Characterization of these distinct proteins and pathways in BMECs will facilitate further elucidation of meningitis-causing mechanisms in humans and animals, thereby enabling the development of novel preventative and therapeutic strategies against infection with meningitic E. coli .

Cholesterol dependent cytolysins and the brain: Revealing a potential therapeutic avenue for bacterial meningitis

Blood-Brain Barrier Integrity Damage in Bacterial Meningitis: the Underlying Link, Mechanisms, and Therapeutic Targets

Resveratrol Attenuates Meningitic Escherichia Coli-Mediated Blood-Brain Barrier Disruption.

Pathogenic Triad in Bacterial Meningitis: Pathogen Invasion, NF-κB Activation, and Leukocyte Transmigration that Occur at the Blood-Brain Barrier

From cytokines to chemokines: Understanding inflammatory signaling in bacterial meningitis

Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response

New insights into meningitic Escherichia coli infection of brain microvascular endothelial cells from quantitative proteomics analysis

Meningeal Immunity and Neurological Diseases: New Approaches, New Insights

Meningitic Escherichia Coli-Induced Upregulation of PDGF-B and ICAM-1 Aggravates Blood-Brain Barrier Disruption and Neuroinflammatory Response

Meningitic <i>escherichia Coli</i> Α-Hemolysin Facilitates Blood-Brain Barrier Disruption Via Targeting Tgfβ1-Induced Hedgehog Signaling

Inflammation‐Activated Endogenous Macrophage‐Mediated Prodrug Delivery System Overcoming Biological Barriers for Enhanced Oral Meningitis Therapy

Meningitic Escherichia coli α-hemolysin aggravates blood–brain barrier disruption via targeting TGFβ1-triggered hedgehog signaling

Bacteria hijack a meningeal neuroimmune axis to facilitate brain invasion

Sphingosine 1-Phosphate Activation of EGFR As a Novel Target for Meningitic Escherichia Coli Penetration of the Blood-Brain Barrier

Cellular Mechanisms of Microbial Proteins Contributing to Invasion of the Blood-Brain Barrier. MicroReview

Group B Streptococcus-Induced Macropinocytosis Contributes to Bacterial Invasion of Brain Endothelial Cells

Induced Pluripotent Stem Cell (iPSC)-Derived Endothelial Cells to Study Bacterial-Brain Endothelial Cell Interactions

HIF-1α is involved in blood-brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis

Evolving Role of Laminin Receptors in Microbial Pathogenesis and Therapeutics of Cns Infection

Selective Loss of Brain-Derived Neurotrophic Factor Exacerbates Brain Injury by Enhancing Neuroinflammation in Experimental <i>Streptococcus pneumoniae</i> Meningitis

The Blood-Brain Barrier: Targeting in the Pathogenesis of C. Neoformans Meningitis and Drug Discovery